Monday, April 4, 2005
lessons learned: Organ Specific Oncologic Therapy-liver (CC)
8:45 a.m. Management/Results of HHT Franklin J. Miller, Jr., MD 9:00 a.m.
Treatment Techniques for PA VMs Jeffrey Pollak, MD
Coordinator / Moderator: S. Nahum Goldberg, MD
Objectives: Upon completion of this course, the attendee should be able to: 1. Illustrate potential methods for improving im-
age-guided tumor ablation in the liver. 2. Successfully treat tumors in radiologically indistinct and difficult to target locations. 3. Discuss novel techniques for achieving large volume ablation. Panelists: Damian E. Dupuy, MD S. Nahum Goldberg, MD Fred T. Lee, Jr., MD Bradford Johns Wood, MD
Management I Results of Vascular Malformation Upper and lower Extremity (ee)
9:15 a.m. PANEL DISCUSSION - ,,-, "'I
,
. Venous Ablation (Pl) Moderator: Melvin Rosenblatt, MD
Objectives: Upon completion of this session, the attendee should be able to: 1. Compare techniques for ablation of the greater and lesser saphenous vein including RF ablation and laser ablation. 2. Review the benefits of direct venous sclerotherapy. 3. Explain the procedure and review the benefits of ambulatory phlebectomy. 4. Describe normal venous anatomy and variance of normal anatomy of the deep and superficial veins of the lower extremities. 5. Illustrate treatment options and techniques for treatment of typical varicose veins.
1. White, MD
10:00 a.m. Dr. Gary j. Becker Young Investigator Award
Objectives: Upon completion of this course, the attendee should be able to:
Presentation Presented by John A. Kaufman, MD
Coordinator / Moderator: Robert j. Rosen, MD & Robert
1. Identify long term results of treatment of low/
high flow vascular malformations of the upper and lower extremity. 2. Indicate number in interventions, adjunctive procedures (plastic surgery) and complications of treatment of low/high vascular malformations of upper and lower extremity. 3. Describe treatment and long-term results for nasal, cerebral, hepatic and gastrointestinal manifestations of Hereditary Hemorrhagic Telangiectasia (HHD. 4. Assess the treatment and long-term clinical and anatomical results of treatment of pulmonary arteriovenous malformations. 8:00 a.m.
Results of Low Flow Patricia E. Burrows, MD 8:15 a.m.
Results ofHigh Flow With Glue Robert J. Rosen, MD
10:05 a.m.
Venous Anatomy and Pathophysiology of Supe1jicial Venous Disease Jose Almeida, MD 10:25 a.m.
Clinical Evaluation of the Patients with Lower Extremity Venous InsuffiCiency Neil Khilnani, MD 10:45 a.m. Endovenous Laser Ablation: Outcomes Robert J. Min, MD, MBA 11:00 a.m.
Endovenous RF Ablation: Outcomes Lowell Kabnick, MD 11:15 a.m. Ambulatory Phlebectomy: Indications and Techniques Michael D. Darcy, MD 11:30 a.m.
8:30 a.m.
Results of High Flow With Alcohol Dominic Yee, MD P226
Sclerotherapy of Large and Small Vessels: Techniques and Outcomes Zachary Rattner, MD
11:45 a.m. Varicosities and Venous Anomalies: The Spectrum of Disease and Treatment Melvin Rosenblatt, MD
Biopsy/Drainage: Case Presentation (CC) Coordinator / Moderator: Brian Funaki, MD
Objectives: Upon completion of this course, the attendee should be able to:
2:15 p.m. Venous Access James Donaldson, MD 2:25 p.m. Abscess Drainage Mark Hogan, MD 2:35 p.m. Renal Interventions Charles James, MD 2:50 p.m.
1. Review current and advanced techniques for percutaneous biopsy and/or drainage. 2. Discuss approach to the coagulopathic patient requiring biopsy and/or drainage. 3. Compare common and uncommon complications of biopsy and/or drainage. 4. Describe methods to perform procedures in poorly accessible lesions.
1:30 p.m. Review Current and Advanced Techniques of Biopsy/Drainage Stephen T. Kee, MD 1:50 p.m. Approach to Coagulopathic Patients John R. Haaga, MD 2:10 p.rn. Complications of Biopsy/Drainage Jeet Sandhu, MD 2:30 p.m. Methods of Biopsy/Drainage in Poorly Accessible Lesions Ronald S. Arellano, MD 2:50 p.m. PANEL DISCUSSION
Pediatric IR for the Non-Pediatric IR (CC) Coordinator / Moderator: Patricia E. Burrows, MD
1:30 p.m. General Principles: Patient Care and Arterial Access Patricia E. Burrows, MD
Q&A
Noninvasive Vascular lab-Building a . " ~~ Vascular Practice (CC) .~ •
Coordinator / Moderator: Keith Sterling, MD
1. Illustrate the importance of the noninvasive vas-
2.
3. 4.
5.
cular laboratory in the diagnosis of peripheral vascular disease. Examine how interventional radiologists can use the noninvasive vascular laboratory to enhance their practice. Discuss the factors necessary to run a successful noninvasive vascular laboratory. Review the technical aspects of all the modalities in the noninvasive vascular laboratory. Demonstrate the interpretation and pitfalls of all the modalities in the noninvasive vascular laboratory.
1:30 p.m. Practice Building and Lab Organization: How To Run a Successful Noninvasive Vascular Practice James F. Benenati, MD 1:50 p.m. Physiologic Arterial Testing for PVD. The Complete Guide to Understanding the Wavefonns Kenneth S. Rholl, MD 2:05 p.m. Duplex Imaging of the Abdominal Aorta, Visceral Arteries, and Lower Extremities Monte Madsen, RDMS, RVT 2:20 p.m. Cerebrovascular Duplex Edward r. Bluth, MD
2:00 p.m.
2:35 p.m. Venous Duplex Ultrasound: Beyond the DVT Robert J. Min, MD
2:05 p.m. GI Interventions Robin Kaye, MD
I
ILll.':'
Objectives: Upon completion of this course, the attendee should be able to:
1:45 p.m. Arterial Interventions Josee Dubois, MD
Q&A
,
2:50 p.m. PANEL DISCUSSION P227